Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia
对于大多数核心结合因子急性髓系白血病患者而言，可测量的残留病灶监测提供的预警时间不足以预防形态学复发。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2019.235721
Puckrin, Robert; Atenafu, Eshetu G; Claudio, Jaime O; Chan, Steven; Gupta, Vikas; Maze, Dawn; McNamara, Caroline; Murphy, Tracy; Shuh, Andre C; Yee, Karen; Sibai, Hassan; Minden, Mark D; Wei, Cuihong; Stockley, Tracy; Kamel-Reid, Suzanne; Schimmer, Aaron D
